0.26
price down icon7.47%   -0.021
after-market Dopo l'orario di chiusura: .26
loading
Precedente Chiudi:
$0.281
Aprire:
$0.261
Volume 24 ore:
76,072
Relative Volume:
0.38
Capitalizzazione di mercato:
$10.15M
Reddito:
-
Utile/perdita netta:
$-117.67M
Rapporto P/E:
-0.0841
EPS:
-3.09
Flusso di cassa netto:
$-101.06M
1 W Prestazione:
-13.62%
1M Prestazione:
-30.89%
6M Prestazione:
-38.92%
1 anno Prestazione:
-89.60%
Intervallo 1D:
Value
$0.251
$0.2886
Intervallo di 1 settimana:
Value
$0.251
$0.3281
Portata 52W:
Value
$0.251
$3.67

Athira Pharma Inc Stock (ATHA) Company Profile

Name
Nome
Athira Pharma Inc
Name
Telefono
(425) 620-8501
Name
Indirizzo
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Name
Dipendente
26
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-07
Name
Ultimi documenti SEC
Name
ATHA's Discussions on Twitter

Confronta ATHA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATHA
Athira Pharma Inc
0.26 10.15M 0 -117.67M -101.06M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-19 Downgrade Mizuho Outperform → Neutral
2024-09-04 Downgrade BTIG Research Buy → Neutral
2024-09-04 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-09-04 Downgrade Rodman & Renshaw Buy → Neutral
2024-08-19 Iniziato Rodman & Renshaw Buy
2022-10-17 Aggiornamento JMP Securities Mkt Perform → Mkt Outperform
2022-07-07 Iniziato Mizuho Buy
2022-06-23 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2022-06-23 Downgrade Jefferies Buy → Hold
2022-06-23 Downgrade Stifel Buy → Hold
2022-05-10 Iniziato BTIG Research Buy
2022-04-21 Iniziato Berenberg Buy
2021-12-15 Iniziato Goldman Neutral
2020-10-13 Iniziato Goldman Buy
2020-10-13 Iniziato JMP Securities Mkt Outperform
2020-10-13 Iniziato Jefferies Buy
2020-10-13 Iniziato Stifel Buy
Mostra tutto

Athira Pharma Inc Borsa (ATHA) Ultime notizie

pulisher
Mar 27, 2025

Athira Pharma stock hits 52-week low at $0.3 amid steep decline By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Athira Pharma stock hits 52-week low at $0.3 amid steep decline - Investing.com Australia

Mar 27, 2025
pulisher
Mar 13, 2025

What is ATHA’s price-to-sales ratio telling us about the company’s value? - US Post News

Mar 13, 2025
pulisher
Mar 11, 2025

Athira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Athira Pharma stock hits 52-week low at $0.33 amid steep decline - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Athira Pharma stock hits 52-week low at $0.33 amid steep decline By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 07, 2025

Athira Pharma Stock Price, Quotes and Forecasts | NASDAQ:ATHA - Benzinga

Mar 07, 2025
pulisher
Mar 03, 2025

Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained - TipRanks

Mar 03, 2025
pulisher
Mar 02, 2025

Athira Pharma’s 2024 Financial Results and Pipeline Progress - MSN

Mar 02, 2025
pulisher
Feb 27, 2025

Athira Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Athira Pharma, Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates - GlobeNewswire

Feb 27, 2025
pulisher
Feb 26, 2025

Athira Pharma stock hits 52-week low at $0.41 amid steep decline - Investing.com Australia

Feb 26, 2025
pulisher
Feb 25, 2025

Athira Pharma stock hits 52-week low at $0.41 amid steep decline By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 24, 2025

Athira Pharma Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 21, 2025

ATHA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Molecular Partners (NASDAQ:MOLN) versus Athira Pharma (NASDAQ:ATHA) Head to Head Review - Defense World

Feb 21, 2025
pulisher
Feb 13, 2025

Athira Pharma (ATHA) Expected to Announce Earnings on Thursday - Defense World

Feb 13, 2025
pulisher
Jan 30, 2025

Alterity stock jumps on data for lead drug (ATHA:NASDAQ) - Seeking Alpha

Jan 30, 2025
pulisher
Jan 28, 2025

Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth? - Yahoo Finance

Jan 28, 2025
pulisher
Jan 21, 2025

Seattle biotech firm Athira Pharma will pay $4M to settle allegations related to research misconduct - MSN

Jan 21, 2025
pulisher
Jan 17, 2025

Insider Buyers Lose Additional US$78k As Athira Pharma Dips To US$21m - Simply Wall St

Jan 17, 2025
pulisher
Jan 14, 2025

Keeping Fraud Out of Research: Government Grant Whistleblower Awarded Over $200,000 - The National Law Review

Jan 14, 2025
pulisher
Jan 14, 2025

Will Athira Pharma See A Boost From LIFT-AD Trial Results In Alzheimer's Research? - RTTNews

Jan 14, 2025
pulisher
Jan 10, 2025

Alzheimer’s Drugmaker Athira Shells Out $4 Million In DOJ Settlement - Being Patient

Jan 10, 2025
pulisher
Jan 08, 2025

Athira to pay $4M to resolve research misconduct allegations - BioWorld Online

Jan 08, 2025
pulisher
Jan 08, 2025

ATHA Stock Earnings: Athira Pharma Beats EPS for Q2 2024 - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

Bothell's Athira Pharma to pay $4M to settle falsified research claims - The Business Journals

Jan 08, 2025
pulisher
Jan 07, 2025

Biotech company agrees to pay $4 million to settle data falsification allegations - Retraction Watch

Jan 07, 2025
pulisher
Jan 06, 2025

Athira Inks $4M FCA Deal Over Ex-CEO's Research Fraud - Law360

Jan 06, 2025
pulisher
Jan 06, 2025

Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research - U.S. Politics Today

Jan 06, 2025
pulisher
Jan 06, 2025

Athira Pharma to Pay $4 Million Over Alleged Research Misconduct - Marketscreener.com

Jan 06, 2025
pulisher
Jan 06, 2025

Bothell pharma company to pay $4 million over falsified research claims - MSN

Jan 06, 2025
pulisher
Jan 06, 2025

Athira Pharma Settles Claims of NIH Research Grant Misconduct - Bloomberg Law

Jan 06, 2025
pulisher
Jan 04, 2025

Athira Pharma CEO sells shares worth $14,107 By Investing.com - Investing.com South Africa

Jan 04, 2025
pulisher
Jan 03, 2025

Athira Pharma CEO sells shares worth $14,107 - Investing.com

Jan 03, 2025
pulisher
Jan 03, 2025

Athira Pharma VP of Finance Sells Shares for $1,618 - Investing.com India

Jan 03, 2025
pulisher
Jan 03, 2025

Athira Pharma VP of Finance Sells Shares for $1,618 By Investing.com - Investing.com Canada

Jan 03, 2025
pulisher
Dec 25, 2024

JMP Securities Downgrades Athira Pharma (ATHA) - MSN

Dec 25, 2024
pulisher
Dec 18, 2024

Athira Pharma Insider Ups Holding By 111% During Year - Yahoo Finance

Dec 18, 2024
pulisher
Dec 13, 2024

Athira Pharma's SWOT analysis: stock faces challenges after trial setback - Investing.com India

Dec 13, 2024

Athira Pharma Inc Azioni (ATHA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):